Skip to content

Validation of the O3 Regional Somatic Tissue Oxygenation Monitor

A Single-Center, Prospective Study in Healthy Volunteers for Validation of the O3 Regional Somatic Tissue Oxygenation Monitor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04584788
Enrollment
37
Registered
2020-10-14
Start date
2020-11-30
Completion date
2021-06-02
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxygen Deficiency

Brief summary

Testing the absolute accuracy of the Masimo O3 regional oximeter in reading somatic tissue oxygenation in healthy volunteers under controlled hypoxia.

Interventions

DEVICEMasimo O3 Regional Oximeter

Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors.

Sponsors

University Medical Center Groningen
CollaboratorOTHER
Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18 and 45 years, inclusive * Willing and able to provide written informed consent * Healthy subjects

Exclusion criteria

* Pregnant women * Presence of any cardiovascular or pulmonary disease * Exposure to high altitude(s) (\>2000 m) within 30 days prior to the study * Known allergy to intravenous contrast medium or heparin * Subject has skin abnormalities affecting the digits such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, nail polish or acrylic nails that would prevent monitoring of SpO2 levels during the study * Patients deemed not suitable for the study at the discretion of the Investigator

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of O3 Sensor by ARMS Calculation of Percent rSO21 visit up to 8 hoursAccuracy of the sensors will be determined by comparing somatic regional oxygen saturation (rSO2) readings from the O3 sensor and blood reference oxygen saturation values and calculating the Arithmetic root mean square (ARMS).

Countries

Netherlands

Participant flow

Participants by arm

ArmCount
Healthy Adult Volunteers
Controlled hypoxia will be induced and Masimo O3 regional oximeter-derived rSO2 readings of somatic tissue will be measured. The readings will be compared with blood reference oxygen saturation values. Masimo O3 Regional Oximeter: Study sensors will be placed on somatic tissues. Readings will be taken from the tissues underneath the O3 sensors.
25
Total25

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event3
Overall StudyPhysician Decision8
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicHealthy Adult Volunteers
Age, Customized
18 to 45 years of age
25 Participants
Age, Customized
< 18 years of age
0 Participants
Age, Customized
> 45 years of age
0 Participants
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 37
other
Total, other adverse events
17 / 37
serious
Total, serious adverse events
1 / 37

Outcome results

Primary

Accuracy of O3 Sensor by ARMS Calculation of Percent rSO2

Accuracy of the sensors will be determined by comparing somatic regional oxygen saturation (rSO2) readings from the O3 sensor and blood reference oxygen saturation values and calculating the Arithmetic root mean square (ARMS).

Time frame: 1 visit up to 8 hours

ArmMeasureValue (NUMBER)
Healthy Adult VolunteersAccuracy of O3 Sensor by ARMS Calculation of Percent rSO24.78 percentage of regional oxygen saturation

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026